Later in 2012, Wang et al. prepared another NP with LyP-1 conjugated PEG-PCL micelles (LyP-1-PM) and Artemisinin (ART) (a natural anti-cancer and anti-lymphangiogenesis drug). The gene discussed is PTPN22; the disease is cancer.